The Future of Medicare’s Coverage with Evidence Development Policy
Jason Shafrin
Senior Managing Director, Center for Healthcare Economics & Policy at FTI Consulting; Adjunct Professor, University of Southern California
That is the title of an interesting panel from USC Schaeffer Center on Coverage with Evidence Development (CED). It includes an interview with Tamara Syrek Jensen, Director, of the Coverage & Analysis Group within the Centers for Medicare & Medicaid Services. After the interview, there is a panel discussion of academics with Darius Lakdawalla of USC, Peter Neumann of Tufts University, and Joshua Makower of Stanford University. A second panel includes a diverse set of healthcare stakeholders including Gregory Daniel, Vice President, Global Public Policy Eli Lilly; John Dwyer, Co-Founder and President of the Global Alzheimer’s Platform Foundation; Perry Bridger, Senior Advisor of Public Affairs at Edwards Lifesciences' and Robert McDonough Senior Director for Clinical Policy Research and Development at Aetna. The video of the full panel is below.
What do you think of CMS's approach to Coverage with Evidence Development?
Health Policy Regulatory and Legislative Expertise; Market Innovator
4 个月It needs to made more useful with interim annual reports and publications of the results. True these are not clinical trials but either the information is valuable to the public or not.